Ezpay

China Biotechnology and Shanghai Liangrun jointly developed a new crown vaccine neutralizing antibody kit, which has obtained the UAE registration certificate with the third phase of the recombinant protein vaccine, and the domestic clinical registration is in progress

The team of Academician Li Xiaokun of Wenzhou Medical University, in cooperation with Shanghai Liangrun, is committed to promoting the emergency monitoring and diagnosis of major acute infectious diseases and abnormal cytokine diseases, and exploring a new development model of the integration of scientific research and industry in medical schools.